Cancer Family
Head and Neck Neoplasm
CI-CAN-00000021Explore in graph →
Non-malignant1,571 active trials17 approved drugs142 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000021Explore in graph →
Clinical trials
6,372 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00982436 | Neoadjuvant Cisplatin/Docetaxel (CDDP/TXT) and Chemoradiation for Head and Neck Cancer | unknown | Phase 1 / Phase 2 | 37 | University of VermontOTHER | 1 | Mar 22, 2012 | clinicaltrials |
| NCT01516996 | Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer | unknown | Phase 2 | 80 | The Second People's Hospital of SichuanOTHER | 1 | Mar 20, 2012 | clinicaltrials |
| NCT00021047 | Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor | completed | Phase 1 / Phase 2 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00697619 | To Evaluate the Efficacy of ZOMETA® in Treatment of Bone Metastases in Patients With Stage IV Nasopharyngeal Cancer | completed | Phase 2 | 60 | Sun Yat-sen UniversityOTHER | 1 | Mar 7, 2012 | clinicaltrials |
| NCT00496236 | Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck Cancer | completed | Phase 1 / Phase 2 | — | GenVecINDUSTRY | 1 | Feb 23, 2012 | clinicaltrials |
| NCT00496535 | A Study of TNFerade™ Biologic With Concomitant Radiotherapy, Fluorouracil, and Hydroxyurea (TNF-FHX) in Patients With Head and Neck Cancer | completed | Phase 1 / Phase 2 | — | GenVecINDUSTRY | 1 | Feb 23, 2012 | clinicaltrials |
| NCT00910117 | Induction Chemotherapy With Nimotuzumab in Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) | completed | Phase 2 | 40 | Fudan UniversityOTHER | 1 | Feb 20, 2012 | clinicaltrials |
| NCT00630149 | Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based Chemotherapy | completed | Phase 2 | 35 | Sun Yat-sen UniversityOTHER | 1 | Feb 16, 2012 | clinicaltrials |
| NCT00279721 | Phase II Study of IMRT With SIB as Adjuvant Treatment for High Risk Resected Well-differentiated Thyroid Cancer. | completed | Phase 2 | 40 | Alberta Health servicesOTHER | 0 | Jan 19, 2012 | clinicaltrials |
| NCT00363441 | A Study of Conventional 3D Radiation vs. Intensity-Modulated Radiation in Squamous Cell Cancer of the Head and Neck | withdrawn | Phase 2 / Phase 3 | 0 | Alberta Health servicesOTHER | 0 | Jan 19, 2012 | clinicaltrials |
| NCT00401401 | Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck Cancer | terminated | Phase 1 / Phase 2 | 30 | GenmabINDUSTRY | 5 | Dec 23, 2011 | clinicaltrials |
| NCT01472653 | Treatment Selection According to Skin Reaction to Cetuximab | unknown | Phase 2 | 120 | Institute of Oncology LjubljanaOTHER | 1 | Dec 13, 2011 | clinicaltrials |
| NCT01313390 | Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck Cancer(DORA) | terminated | Phase 1 / Phase 2 | 4 | University College, LondonOTHER | 1 | Dec 12, 2011 | clinicaltrials |
| NCT00425750 | Bortezomib and Docetaxel in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | completed | Phase 2 | 25 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Nov 16, 2011 | clinicaltrials |
| NCT00169221 | Post-operative Radiotherapy With Cisplatin Alone or in Combination With Iressa in Upper Aerodigestive Tract Carcinomas | terminated | Phase 2 | 54 | Groupe Oncologie Radiotherapie Tete et CouOTHER | 1 | Nov 15, 2011 | clinicaltrials |
| NCT01449942 | Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma(NPC-DZ) | completed | Phase 1 / Phase 2 | 40 | Xiangya Hospital of Central South UniversityOTHER | 1 | Oct 10, 2011 | clinicaltrials |
| NCT00941135 | Safety and Efficacy Study in Patients With Local Advanced Larynx/Hypolarynx Carcinoma Treated With TPF Induction Chemotherapy Followed by Hyperfractionated Radiotherapy With Cetuximab | terminated | Phase 2 | 70 | Fundacion Miguel ServetOTHER | 1 | Sep 29, 2011 | clinicaltrials |
| NCT00796952 | Muscle Composition and Function for Swallowing in Head/Neck Cancer Patients(Pharyngocise) | completed | Phase 2 | 58 | University of FloridaOTHER | 1 | Sep 20, 2011 | clinicaltrials |
| NCT00805012 | Docetaxel and S-1 in Head and Neck Squamous Cell Carcinoma (HNSCC) | terminated | Phase 2 | 96 | Seoul National University HospitalOTHER | 1 | Jul 26, 2011 | clinicaltrials |
| NCT00855881 | Metronomic Chemotherapy With Tegafur/Uracil for Head and Neck Squamous Cell Carcinoma | unknown | Phase 2 | 115 | Mackay Memorial HospitalOTHER | 1 | Jul 26, 2011 | clinicaltrials |
| NCT00054054 | S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck Cancer | completed | Phase 2 | — | SWOG Cancer Research NetworkNETWORK | 2 | Jul 25, 2011 | clinicaltrials |
| NCT01086488 | Foscan®-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Nasopharyngeal Carcinoma(FOSCAN) | unknown | Phase 2 | 66 | Ministry of Health, MalaysiaOTHER_GOV | 1 | Jul 8, 2011 | clinicaltrials |
| NCT00169247 | Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx Preservation | completed | Phase 2 | 156 | Groupe Oncologie Radiotherapie Tete et CouOTHER | 1 | Jun 27, 2011 | clinicaltrials |
| NCT00004048 | Radioimmunotherapy With or Without Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Thyroid Cancer | completed | Phase 1 / Phase 2 | 30 | Garden State Cancer Center at the Center for Molecular Medicine and ImmunologyOTHER | 1 | Jun 22, 2011 | clinicaltrials |
| NCT01377298 | Pazopanib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma | unknown | Phase 2 | 45 | National Taiwan University HospitalOTHER | 1 | Jun 21, 2011 | clinicaltrials |
| NCT01301248 | Cisplatin Chemoradiation With or Without Cetuximab for Locoregionally Advanced Squamous Cell Carcinomas (SCC) of the Head and Neck | unknown | Phase 2 | 80 | Theagenio Cancer HospitalOTHER_GOV | 1 | May 17, 2011 | clinicaltrials |
| NCT00002506 | Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer | completed | Phase 2 | — | Hoag Memorial Hospital PresbyterianOTHER | 1 | May 12, 2011 | clinicaltrials |
| NCT00216138 | Docetaxel and Capecitabine for First Line Treatment of Metastatic Squamous Cell Carcinoma of the Head & Neck | terminated | Phase 2 | 19 | Hoosier Cancer Research NetworkOTHER | 1 | May 2, 2011 | clinicaltrials |
| NCT01024101 | Early Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Advanced or Recurrent Head and Neck Cancer | completed | Phase 2 | 36 | Bristol-Myers SquibbINDUSTRY | 0 | Apr 25, 2011 | clinicaltrials |
| NCT01312311 | Weekly Docetaxel Plus Cisplatin as the First-line Therapy for Nasopharyngeal Cancer | unknown | Phase 2 | 51 | Samsung Medical CenterOTHER | 1 | Mar 10, 2011 | clinicaltrials |
| NCT01291095 | Accelerated Fractionation Radiotherapy (AFRT) Versus Concurrent Chemoradiotherapy (Crt) In Locally Advanced Head And Neck Squamous Cell Carcinoma | unknown | Phase 2 | 80 | All India Institute of Medical SciencesOTHER | 1 | Mar 4, 2011 | clinicaltrials |
| NCT00625937 | Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer | unknown | Phase 2 | 46 | Yonsei UniversityOTHER | 1 | Feb 28, 2011 | clinicaltrials |
| NCT00233636 | Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck | withdrawn | Phase 2 | 28 | AstraZenecaINDUSTRY | 1 | Jan 27, 2011 | clinicaltrials |
| NCT00242762 | ZD1839 (IRESSA™) in Combination With Docetaxel & Cisplatin in Subjects With Metastatic Head & Neck Cancer | completed | Phase 2 | 36 | AstraZenecaINDUSTRY | 1 | Jan 27, 2011 | clinicaltrials |
| NCT00401323 | Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma | completed | Phase 2 / Phase 3 | 568 | SanofiINDUSTRY | 20 | Jan 20, 2011 | clinicaltrials |
| NCT00786552 | Pemetrexed + Paclitaxel in Patients With Recurrent/Advanced Thyroid Cancer(Panthera) | unknown | Phase 2 | 47 | University Hospital Schleswig-HolsteinOTHER | 1 | Jan 20, 2011 | clinicaltrials |
| NCT01265147 | Intensity-modulated Radiation Therapy Combined With Cisplatin or Nedaplatin Chemotherapy in Nasopharyngeal Carcinoma | unknown | Phase 2 | 20 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityOTHER | 1 | Jan 20, 2011 | clinicaltrials |
| NCT00357617 | Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery | unknown | Phase 1 / Phase 2 | 24 | Centre Hospitalier Universitaire VaudoisOTHER | 1 | Dec 24, 2010 | clinicaltrials |
| NCT01260480 | An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation | unknown | Phase 2 | 60 | Aposense Ltd.INDUSTRY | 1 | Dec 17, 2010 | clinicaltrials |
| NCT00436293 | Taxotere + Cisplatin in Nasopharyngeal Carcinoma | completed | Phase 2 | 61 | SanofiINDUSTRY | 1 | Nov 17, 2010 | clinicaltrials |
| NCT00252473 | S-Frame CT Immobilization Masks For Patients Undergoing Radiation Therapy For Head and Neck Cancer | completed | Phase 2 | 30 | University Health Network, TorontoOTHER | 1 | Aug 13, 2010 | clinicaltrials |
| NCT00363831 | Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma | unknown | Phase 2 | 42 | The University of Hong KongOTHER | 1 | Jul 28, 2010 | clinicaltrials |
| NCT00634595 | Trial of E10A in Head and Neck Cancer | unknown | Phase 2 | 116 | Sun Yat-sen UniversityOTHER | 1 | Jul 28, 2010 | clinicaltrials |
| NCT00647140 | Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid Cancer(DOPMET) | terminated | Phase 2 | 29 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jul 7, 2010 | clinicaltrials |
| NCT00193284 | Chemotherapy Plus Gefitinib Followed by Chemotherapy, Radiation Therapy, and Gefitinib For Head and Neck Cancer | completed | Phase 2 | 50 | SCRI Development Innovations, LLCOTHER | 1 | Jun 22, 2010 | clinicaltrials |
| NCT00060242 | Combretastatin A4 Phosphate in Treating Patients With Advanced Anaplastic Thyroid Cancer | completed | Phase 2 | 26 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00077103 | Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer | terminated | Phase 1 / Phase 2 | 4 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00371566 | A Study Of Lapatinib Versus Placebo Followed By Chemoradiation In Patients With Locally Advanced Head And Neck Cancer | completed | Phase 2 | 107 | GlaxoSmithKlineINDUSTRY | 5 | Apr 6, 2010 | clinicaltrials |
| NCT00700440 | Study of Cetuximab in Nasopharyngeal Carcinoma (NPC) With Chemoradiotherapy(ENCORE) | completed | Phase 2 | 100 | Sun Yat-sen UniversityOTHER | 1 | Mar 26, 2010 | clinicaltrials |
| NCT01073683 | Induction Docetaxel/Cisplatin/5-fluorouracil (TPF) as Selector for Chemo Radiation Therapy (RT) Versus Partial Laryngectomy in Advanced Laryngeal Cancer | unknown | Phase 2 | 100 | Rabin Medical CenterOTHER | 1 | Mar 5, 2010 | clinicaltrials |
Data updated 23 days agoSource updated Mar 22, 2012source: clinicaltrials